These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Visfatin--a true or false trail to type 2 diabetes mellitus. Arner P J Clin Endocrinol Metab; 2006 Jan; 91(1):28-30. PubMed ID: 16401830 [No Abstract] [Full Text] [Related]
6. Do resistin-induced changes in tissue blood perfusion play a role in the pathogenesis of type 2 diabetes? Guo XR Acta Physiol (Oxf); 2009 Feb; 195(2):203. PubMed ID: 19132957 [No Abstract] [Full Text] [Related]
7. Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes? Perrini S; Cignarelli A; Ficarella R; Laviola L; Giorgino F Arch Physiol Biochem; 2009 Oct; 115(4):218-26. PubMed ID: 19780715 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Corbould A Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869 [TBL] [Abstract][Full Text] [Related]
10. [Current viewpoints on the risks of various types of fat distribution]. Seidell JC; den Tonkelaar I; van Noord PA; Baanders-van Halewijn EA Ned Tijdschr Geneeskd; 1990 Sep; 134(37):1779-82. PubMed ID: 2215741 [No Abstract] [Full Text] [Related]
11. [The adipose tissue: an essential site of the regulation of metabolism]. Renold AE Praxis; 1966 Jun; 55(22):623-9. PubMed ID: 6014177 [No Abstract] [Full Text] [Related]
12. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995 [TBL] [Abstract][Full Text] [Related]
13. Metabolic recovery of adipose tissue is associated with improvement in insulin resistance in a model of experimental diabetes. Takada J; Fonseca-Alaniz MH; de Campos TB; Andreotti S; Campana AB; Okamoto M; Borges-Silva Cd; Machado UF; Lima FB J Endocrinol; 2008 Jul; 198(1):51-60. PubMed ID: 18451064 [TBL] [Abstract][Full Text] [Related]
14. Obesity causes a shift in metabolic flow of gangliosides in adipose tissues. Tanabe A; Matsuda M; Fukuhara A; Miyata Y; Komuro R; Shimomura I; Tojo H Biochem Biophys Res Commun; 2009 Feb; 379(2):547-52. PubMed ID: 19116132 [TBL] [Abstract][Full Text] [Related]
15. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693 [TBL] [Abstract][Full Text] [Related]
16. Role of renin-angiotensin system in adipose tissue dysfunction. Iwai M; Horiuchi M Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825 [TBL] [Abstract][Full Text] [Related]
17. [Fetal origins of type 2 diabetes]. Beltrand J; Lévy-Marchal C Arch Pediatr; 2008 Jun; 15(5):537-9. PubMed ID: 18582664 [No Abstract] [Full Text] [Related]
18. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Girard J; Lafontan M Diabetes Metab; 2008 Nov; 34(5):439-45. PubMed ID: 18562233 [TBL] [Abstract][Full Text] [Related]
19. Decorin is a secreted protein associated with obesity and type 2 diabetes. Bolton K; Segal D; McMillan J; Jowett J; Heilbronn L; Abberton K; Zimmet P; Chisholm D; Collier G; Walder K Int J Obes (Lond); 2008 Jul; 32(7):1113-21. PubMed ID: 18414424 [TBL] [Abstract][Full Text] [Related]
20. [The importance of the brain for the regulation of energy and glucose metabolism]. Rother E; Jordan SD; Brüning JC Dtsch Med Wochenschr; 2009 May; 134(20):1057-9. PubMed ID: 19421928 [No Abstract] [Full Text] [Related] [Next] [New Search]